Statin Use in Metabolic Dysfunction-Associated Steatotic Liver Disease and Effects on Vibration-Controlled Transient Elastography-Derived Scores—A Population-Based Inverse Probability Treatment Weighting Analysis

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease globally. The impact of statins on liver fibrosis severity in MASLD individuals remains uncertain, despite their known cardiovascular benefits. Methods: A cross-secti...

Повний опис

Бібліографічні деталі

Автори:	Natchaya Polpichai, Sakditad Saowapa, Aunchalee Jaroenlapnopparat, Leandro Sierra, Pojsakorn Danpanichkul, Panisara Fangsaard, Phuuwadith Wattanachayakul, Apichat Kaewdech
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2024-12-01
Серія:	Livers
Предмети:	Statins MASLD NAFLD MASH NASH liver fibrosis
Онлайн доступ:	https://www.mdpi.com/2673-4389/4/4/46
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!